DJIA 16,987.51 -61.49 -0.36%
NASDAQ 4,567.60 -24.21 -0.53%
S&P 500 1,985.54 -11.91 -0.60%
market minute promo

GlaxoSmithKline (NYSE: GSK)

47.06 0.13 (0.28%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

GSK $47.06 0.28%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $47.14
Previous Close $46.93
Daily Range $46.90 - $47.14
52-Week Range $46.01 - $56.73
Market Cap $113.0B
P/E Ratio 16.13
Dividend (Yield) $2.59 (5.7%)
Ex-Dividend Date
Dividend Pay Date
Volume 2,958,504
Average Daily Volume 3,785,530
Current FY EPS $3.19





GlaxoSmithKline (GSK) Description

The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products. Website:

News & Commentary

COPD Occurs Most Often in These 5 States

COPD affects more than 6% of the U.S. population and costs $50 billion in direct and indirect costs annually, but these five states have the highest occurrence rate in the country.

Vectura Group Following A Familiar Path

Trading Guidelines for J&J, Merck, Pfizer, 8 Other Drug Companies

Why Amarin Corporation plc Stock Cratered

Amarin's stock is plunging today. Here's why.

Marijuana & Antidotes: GSK & CEMP Nursing Pulmonary Diseases

Evaluating GlaxoSmithKline's Intrinsic Value

Dividend Quick Picks: Foreign Stocks

Ebola: Desperate Days Ahead

Ligand Inks 2nd Captisol Deal with CURx Pharmaceuticals - Analyst Blog

Trade Ebola Stocks? Sure, But Don't Bet on Big Business Opportunity

See More GSK News...

GSK's Top Competitors

GSK $47.06 (0.28%)
Current stock: GSK
JNJ $104.58 (0.03%)
Current stock: JNJ
NVS $93.76 (-0.64%)
Current stock: NVS
RHHBY $36.70 (-0.54%)
Current stock: RHHBY